Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment using truncated Trk B and Trk C antagonists

Treatment using truncated Trk B and Trk C antagonists

US Patent 10066229 · Granted Sep 4, 2018

Estimated economic value: $2,130,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Auris formulations for treating otic diseases and conditions2024
Triglyceride otic formulations and uses thereof2024
Carbohydrate structures and uses thereof2023
Controlled release antimicrobial compositions and methods for the treatment of o2022
Auris formulations for treating OTIC diseases and conditions2021
Auris formulations for treating otic diseases and conditions2021
Treatment using truncated Trk B and Trk C antagonists2021
Treatment using truncated Trk B and Trk C antagonists2021
Controlled-release CNS modulating compositions and methods for the treatment of 2021
Triglyceride otic formulations and uses thereof2020
Controlled release antimicrobial compositions and methods for the treatment of o2020
Auris formulations for treating otic diseases and conditions2020